GSK3β negatively regulates LPS-induced osteopontin expression via inhibiting its transcription.

H Song,B Deng,C Zou,W Huai,R Zhao,W Zhao
DOI: https://doi.org/10.1111/sji.12268
2015-01-01
Scandinavian Journal of Immunology
Abstract:Osteopontin (OPN) is expressed by a variety of immune cells and is critical for both innate and adaptive immune responses. The expression status of OPN might be tightly regulated to maintain immune homeostasis. However, the mechanisms by which OPN is negatively regulated in LPS-stimulated macrophages remain largely unknown. In this study, we showed that glycogen synthase kinase 3 (GSK3) inhibitors - SB216763, LiCl and azakenpaullone - enhanced LPS-induced OPN expression in mouse peritoneal macrophages. GSK3 knock-down had the similar effects. Furthermore, we found that GSK3 inhibitors and GSK3 knock-down both increased the activity of OPN promoter in LPS-stimulated macrophages. GSK3 inhibitor-mediated enhancement of LPS-induced OPN promoter activity was abrogated in GSK3 siRNA-treated macrophages. Therefore, we identified GSK3 as a negative regulator of OPN expression and suggest GSK3 as a potential therapeutic target for the intervention of diseases with uncontrolled OPN production.
What problem does this paper attempt to address?